Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MS

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

NCT02861014 ·Status: COMPLETED ·Phase: PHASE3

Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMS

NCT04838015 ·Status: UNKNOWN

Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis

NCT03138525 ·Status: COMPLETED

Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.

NCT04877457 ·Status: TERMINATED ·Phase: PHASE4

A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)

NCT06780150 ·Status: RECRUITING

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis

NCT03972306 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)

NCT04548999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

NCT05834855 ·Status: RECRUITING ·Phase: PHASE3

Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis

NCT04834401 ·Status: COMPLETED

Ocrelizumab Effects on the Metabolome in MS

NCT03873389 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

NCT04544449 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

NCT01194570 ·Status: COMPLETED ·Phase: PHASE3

T Cell Profiling in Patients with Multiple Sclerosis

NCT04789551 ·Status: NOT_YET_RECRUITING

Effects of Ocrevus in Relapsing Multiple Sclerosis

NCT04387734 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

NCT02545868 ·Status: COMPLETED ·Phase: PHASE3

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

NCT05245344 ·Status: UNKNOWN

Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM

NCT03784547 ·Status: UNKNOWN

A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)

NCT00239655 ·Status: TERMINATED ·Phase: PHASE2

A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis

NCT05906992 ·Status: RECRUITING ·Phase: PHASE3

A Study To Determine The Effect Of Ocrelizumab On Leptomeningeal Inflammation In Multiple Sclerosis

NCT05208840 ·Status: WITHDRAWN ·Phase: PHASE4

Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)

NCT02688985 ·Status: COMPLETED ·Phase: PHASE3

Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis

NCT04261790 ·Status: COMPLETED ·Phase: PHASE4

Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714

NCT03691077 ·Status: UNKNOWN ·Phase: PHASE3

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

NCT04578639 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis

NCT03593590 ·Status: COMPLETED